Quality of life in patients with chronic kidney disease

Abstract

Aim to study the quality of life (QOL) of patients with chronic kidney disease (CKD) in the Republic of Tajikistan.

Materials and Methods. The study was conducted in 2016-2018 and included 319 patients, with CKD (of them 58.9% men, with CKD I-IV stages – 121, receiving long term hemodialysis – 109, after kidney transplantation – 89) and 103 relatively healthy individuals (control group, men – 53.4%). The main causes of CKD were glomerulonephritis, diabetes mellitus, and pyelonephritis. QOL was evaluated by the SF-36.

Results. Impairment of the quality of life in patients with CKD was demonstrated in most parameters, both in comparison with the control group and with progression of CKD. In the terminal stage of CKD the quality of life evaluated by some parameters (bodily pain, general health, physical health, social functioning) was lower in patients dependent on program hemodialysis than in patients after kidney transplantation. The parameters of mental and psychological health did not show any differences between these groups which is explained by the authors as due to lack of psychological support after surgical intervention, to necessity of using immunosuppressive therapy and to the economical constituent of treatment.

Conclusions. Evaluation of the quality of life should be an obligatory component of the analysis of the quality and effectiveness of management of patients with chronic kidney disease including those at the terminal stage. In the work, impairment of the quality of life and of its separate parameters in progression of chronic kidney disease was objectively demonstrated. At the terminal stage, the quality of life evaluated by some most important parameters was lower in patients receiving program hemodialysis that in patients after transplantation of kidney.

Keywords

chronic kidney disease / quality of life / transplantation / hemodialysis / SF-36

References

[1] Chubutiya MS, Gulov МК, Ismoilov SS, et al. Prognostic risk factors of early transplant dysfunction after relative kidney transplantation. Health Care of Tajikistan. 2016;331(4):51-9. (In Russ).

[2] Хубутия М.Ш., Гулов М.К., Исмоилов С.С., и др. Прогностические факторы риска развития ранних дисфункций трансплантата после родственной пересадки почки // Здравоохранение Таджикистана. 2016. Т. 331, №4. С. 51-59.

[3] Pirov BS, Pikiren’ya II, Kalmykov EL, et al. Cytomegalovirus and bacterial infection in donors and recipients in kidney transplantation. I.P. Pavlov Russian Medical Biological Herald. 2015;23(4):17-20. (In Russ).

[4] Пиров Б.С., Пикиренъя И.И., Калмыков Е.Л., и др. Цитомегаловирусная и бактериальная инфекция у доноров и реципиентов при трансплантации почек // Российский медико-биологи-ческий вестник имени академика И.П. Павлова. 2015. Т. 23, №4. С. 17-20.

[5] Smirnov AP, Mashkina EA. Economic efficiency of kidney transplantation in comparison with hemodialysis program among patients with terminal stage of chronic renal insufficiency. International Research Journal. 2017;63(9-2):31-3. (In Russ). doi:10.23670/irj.2017.63.031

[6] Смирнов А.П., Машкина Е.А. Экономическая эффективность трансплантации почки в сравнении с программным гемодиализом у больных с терминальной стадией хронической почечной недостаточности // Международный научно-ис-следовательский журнал. 2017. Т. 63, №9-2. С. 31-33. doi:10.23670/irj.2017.63.031

[7] Khubutia MSh, Gulov MK, Ismoilov SS, et al. The prognostic value of risk factors having influence to long-term survival of patients and transplants after living-related kidney transplantation. Bulletin Avi-cenna Scientific Medical Journal. 2016;68 (3):7-13. (In Russ).

[8] Хубутия М.Ш., Гулов М.К., Исмоилов С.С., и др. Прогностическая ценность факторов риска, влияющих на длительность выживания больных и трансплантатов после родственной пересадки почки // Вестник Авиценны. 2016. Т. 68, №3. С. 7-13.

[9] Kalmykov E.L. An Overview of the Cologne Symposium on Issue of Vascular Access in Patients on Progmammic Hemodialysis («Kölner Dialyseshunt Symposium», June, 24-25, 2016 year). Novosti Khirurgii. 2017;25(2):211-4. (In Russ). doi:10.18484 /2305-0047.2017.2.211

[10] Калмыков Е.Л. Обзор Кёльнского симпозиума по проблеме сосудистого доступа у пациентов находящихся на программном гемодиализе («Kölner Dialyseshunt Symposium», 24-25 июня 2016 года) // Новости хирургии. 2017. Т. 25, №2. С. 211-214. doi:10.18484/2305-0047.2017.2.211

[11] Vasilieva IA, Dobronravov VA, Panina IYu, et al. Quality of life in patients with different stages of chronic kidney disease. Nefrology. 2013;17(2):60-5. (In Russ). doi:10.24884/1561-6274-2013-17-2-60-65

[12] Васильева И.А., Добронравов В.А., Панина И.Ю., и др. Качество жизни больных на различных стадиях хронической болезни почек // Нефрология. 2013. Т. 17, №2. С. 60-65. doi:10.24884/ 1561-6274-2013-17-2-60-65

[13] Gazhva SI, Zagaynov VE, Igolkina NA, et al. Quality of life of patients with chronic kidney disease undergoing hemodialysis. Modern Problems of Science and Education. 2013;3:96. (In Russ).

[14] Гажва С.И., Загайнов В.Е., Иголкина Н.А., и др. Качество жизни пациентов с хронической болезнью почек, находящихся на гемодиализе // Современные проблемы науки и образования. 2013. №3. С. 96.

[15] Elfimov DA, Elfimova IV, Moreva GV, et al. Izucheniye kachestva zhizni u patsiyentov s khronicheskoy bolezn’yu pochek. Universitetskaya meditsina Urala. 2017;3(3,10):14-6. (In Russ).

[16] Елфимов Д.А., Елфимова И.В., Морева Г.В., и др. Изучение качества жизни у пациентов с хронической болезнью почек // Университетская медицина Урала. 2017. Т. 3, №3 (10). С. 14-16.

[17] Joshi VD. Quality of life in end stage renal disease patients. World Journal of Nephrology. 2014; 3(4):308-16. doi:10.5527/wjn.v3.i4.308

[18] Joshi V.D. Quality of life in end stage renal disease patients // World Journal of Nephrology. 2014. Vol. 3, №4. P. 308-316. doi:10.5527/wjn.v3.i4.308

[19] Manavalan M, Majumdar A, Harichandra Ku-mar KT, et al. Assessment of health-related quality of life and its determinants in patients with chronic kidney disease. Indian Journal of Nephrology. 2017;27(1):37-43. doi:10.4103/0971-4065.179205

RIGHTS & PERMISSIONS

Gulov M.K., Abdulloev S.M., Rofiev K.K.